These medicines, on a peripheral level, inhibit stomach emptying and intestinal motility, hence extending satiety signals
Current perspectives include: setmelanotide (Imcivree, Rhythm Pharmaceuticals, FDA-approved 2020), selective MC4R agonist for rare monogenic obesities (LEPR, POMC, PCSK1 deficit, Bardet-Biedl syndrome)
It is often selected when the goal is to enhance cellular turnover, improve skin texture, and support visible tissue repair
The cooling hydrogel patches hug the contours of the eye area to help deliver these ingredients while providing a soothing, de-puffing effect in as little as 10 minutes
Al activar telomerasa, Epithalon reduce los errores acumulativos en el ADN [3][4]
Leucine rich repeat kinase 2 and innate immunity